Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.010
-0.010 (-0.98%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cue Biopharma Employees
Cue Biopharma had 53 employees as of December 31, 2023. The number of employees increased by 1 or 1.92% compared to the previous year.
Employees
53
Change (1Y)
1
Growth (1Y)
1.92%
Revenue / Employee
$179,849
Profits / Employee
-$841,736
Market Cap
63.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InterCure | 270 |
OptiNose | 132 |
Hyperfine | 131 |
BeyondSpring | 36 |
Oncolytics Biotech | 29 |
HeartBeam | 15 |
Regencell Bioscience Holdings | 12 |
CUE News
- 22 days ago - Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 26 days ago - Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Cue Biopharma Announces Strategic Organizational Transition - GlobeNewsWire
- 6 weeks ago - Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting - GlobeNewsWire
- 2 months ago - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 3 months ago - Cue Biopharma Announces Pricing of $12.0 Million Public Offering - GlobeNewsWire
- 3 months ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire